The safety of drugs for the treatment of nausea and vomiting of pregnancy

Expert Opinion on Drug Safety

Volumn 6, Issue 6, 2007, Pages 685-694

  Gill, Simerpal K ^a,b   Einarson, Adrienne ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antiemetics; Drug safety; Nausea and vomiting of pregnancy; NVP; Teratogenicity

Indexed keywords

ALIZAPRIDE; ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; BENDECTIN; BENZODIAZEPINE DERIVATIVE; BUCLIZINE; BUTYROPHENONE; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEBENDOX; DICYCLOVERINE; DIMENHYDRINATE; DOMPERIDONE; DOXYLAMINE; DROPERIDOL; HISTAMINE H1 RECEPTOR ANTAGONIST; MECLOZINE; METOCLOPRAMIDE; ONDANSETRON; PHENOTHIAZINE; PROCHLORPERAZINE; PROMETHAZINE; PYRIDOXINE; SEROTONIN ANTAGONIST; THIETHYLPERAZINE; TRIFLUOPERAZINE; TRIMETHOBENZAMIDE; UNINDEXED DRUG; VITAMIN;

ADD ON THERAPY; ADJUVANT THERAPY; ANTIEMETIC ACTIVITY; CHEMOTHERAPY INDUCED EMESIS; CLEFT PALATE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONGENITAL MALFORMATION; CONTINUOUS INFUSION; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENDOCRINE DISEASE; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; FLUID RESUSCITATION; HOSPITALIZATION; HUMAN; HYPEREMESIS GRAVIDARUM; LOW BIRTH WEIGHT; LOW DRUG DOSE; MENTAL DISEASE; MONOTHERAPY; MORNING SICKNESS; NAUSEA AND VOMITING; NONHUMAN; PATIENT SAFETY; PHYSICAL DISABILITY; PREGNANCY DISORDER; PREGNANCY TERMINATION; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SOCIAL DISABILITY; SOMNOLENCE; SPONTANEOUS ABORTION; TERATOGENICITY; WELLBEING; WITHDRAWAL SYNDROME; WORK DISABILITY; ANIMAL; FEMALE; NAUSEA; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT; VOMITING;

ANIMALS; ANTIEMETICS; FEMALE; HUMANS; NAUSEA; PREGNANCY; PREGNANCY COMPLICATIONS; VOMITING;

EID: 38449086347     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.6.6.685     Document Type: Review

References (74)

1. NGUYEN P, EINARSON A: Managing nausea and vomiting of pregnancy with pharmacological and nonpharmacological treatments. Fut. Med. (2006) 2:753-760.
2. VELLACOTT I, COOKE E, JAMES E: Nausea and vomiting in early pregnancy. Int. J. Gynaecol. Obstet. (1988) 27:57-62.
3. MILLER F: Nausea and vomiting in pregnancy: the problem of perception - is it really a disease? Am. J. Obstet. Gynecol. (2002) 186:S182-S183.
4. SHERMAN P, FLAXMAN S: Nausea and vomiting of pregnancy in an evolutionary perspective. Am. J. Obstet. Gynecol. (2002) 186:S190-S197.
5. ATTARD C, KOHLI M, COLEMAN S et al.: The burden of illness of severe nausea and vomiting of pregnancy in the United States. Am. J. Obstet. Gynecol. (2002) 186:S220-S227.
6. BADELL M, RAMIN S, SMITH J: Treatment options for nausea and vomiting during pregnancy. Pharmacotherapy (2006) 26:1273-1287.
7. PIWKO C, UNGAR W, EINARSON T, WOLPIN J, KOREN G: The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto motherisk program. Curr. Med. Res. Opin. (2007) 23:833-840.
8. BASHIRI A, NEWMANN L, MAYMON E, KATZ M: Hyperemesis gravidarum: epidemiological features, complications and outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. (1995) 63:135-138.
9. ELIAKIM R, OVADIA A, SHERER D: Hyperemesis gravidarum: a current review. Am. J. Perinat. (2000) 17:207-218.
10. DEPUE R, BERNSTEIN L, ROSS R, JUDD H, HENDERSON B: Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiology study. Am. J. Obstet. Gynecol. (1987) 156:1137-1141.
11. HAYAKAWA S, NAKAJIMA N, KARASAKI-SUZUKI M et al.: Frequent presence of Helicobacter pylori genome in the saliva of patients with Hyperemesis gravidarum. Am. J. Perinat. (2000) 17:243-247.
12. FRIGO P, LANG C, REISENBERGER K, KÖLBL H, HIRSCHL A: Hyperemesis gravidarum associated with Helicobacter pylori seropositivity. Obstet. Gynecol. (1998) 91:615-617.
13. JACOBY E, PORTER K: Helicobacter pylori infection and persistent Hyperemesis gravidarum. Am. J. Perinat. (1999) 16:85-88.
14. VERBERG M, GILLIOT D, AL-FARDAN N, GRUDZINSKAS J: Hyperemesis gravidarum, a literature review. Hum. Reprod. Update (2005) 11:527-539.
15. DAVIS M: Nausea and vomiting of pregnancy: an evidence-based review. J. Perinat. Neonat. Nurs. (2004) 18:312-328.
16. HOD M, ORVIETO R, KAPLAN B, FRIEDMAN S, OVADIA J: Hyperemesis gravidarum: a review J. Reprod. Med. (1994) 39:605-612.
17. KOCH K: Gastrointestinal factors in nausea and vomiting of pregnancy. Am. J. Obstet. Gynecol. (2002) 186:S198-S203.
18. KOCH K: Review article: clinical approaches to unexplained nausea and vomiting. Adv. Gastroenterol Hepatol. Clin. Nutr. (1998) 3:163-178.
19. LOUIK C, HERNANDEZ-DIAZ S, WERLER M, MITCHELL A: Nausea and vomiting in pregnancy: maternal characteristics and risk factors. Paediatr. Perinat. Epidemiol. (2006) 20:270-278.
20. KOREN G, PAIRAUDEAU N: Compliance with prenatal vitamins. Patients with morning sickness sometimes find it difficult. Can. Fam. Phys. (2006) 52:1392-1393.
21. CHANDRA K, MAGEE L, EINARSON A, KOREN G: Nausea and vomiting in pregnancy: results of a survey that identified interventions used by women to alleviate their symptoms. J. Psychosom. Obstet. Gynaecol. (2003) 24:71-75.
22. JEWELL D, YOUNG G: Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst. Rev. (2003) 4:CD000145.
23. LEVICHEK Z, ATANACKOVIC G, OEPKES D et al.: Nausea and vomiting of pregnancy. Evidence-based treatment algorithm. Can. Fam. Phys. (2002) 48:267-277.
24. BISHAI R, MAZZOTTA P, ATANACKOVIC G et al.: Critical appraisal of drug therapy for nausea and vomiting of pregnancy. II. Efficacy and safety of diclectin (doxylamine-B6). Can. J. Clin. Pharmacol. (2000) 7:138-143.
25. BOSKOVIC R, EINARSON A, MALTEPE C, WOLPIN J, KOREN G: Diclectin therapy for nausea and vomiting of pregnancy: effects of optimal dosing. J. Obstet. Gynaecol. Can. (2003) 25:830-833.
26. ATANACKOVIC Z, NAVIOZ Y, MORETTI M, KOREN G: The safety of higher than standard dose of doxylamine-pyridoxine (diclectin) for nausea and vomiting of pregnancy. J. Clin. Pharmacol. (2001) 41:842-845.
27. BRENT R: The Bendectin Saga: another American tragedy. Teratology (1983) 27:283-286.
28. EINARSON T, LEEDER J, KOREN G: A method for meta-analysis of epidemiological studies. Drug Intell. Clin. Pharm. (1988) 22:813-824.
29. MCKEIGUE P, LAMM S, LINN S, KUTCHER J: Bendectin and birth defects. I. A meta-analysis of the epidemiologic studies. Teratology (1994) 50:27-37.
30. CARTWRIGHT E: Dramamine in nausea and vomiting of pregnancy. West J. Surg. (1951) 59:216-234.
31. KING A: The treatment of nausea and vomiting with a pill. Obstet. Gynecol. (1955) 6:332-338.
32. MCCOLL J, GLOBUS M, ROBINSON S: Effect of some therapeutic agents in the developing rat fetus. Toxicol. Appl. Pharmacol. (1965) 7:409-417.
33. SCAHTZ M, PETITTI D: Anti-histamines and pregnancy. Ann. Allergy Ashthma Immunol. (1997) 78:157-159.
34. MELLIN G, KATZENSTEIN M: Medozine and foetal abnormalities. Lancet (1963) 1:222-223.
35. BRIGGS G, FREEMAN R, YAFFE S (Eds): Drugs in Pregnancy and Lactation. (5th Edition). Williams and Wilkins, Baltimore, USA (1998).
36. HEINONEN O, SLONE D, SHAPIRO S (Eds): Birth Deficts and Drugs in Pregnancy. Publishing Sciences Group, Littleton, MA, USA (1977).
37. MICHAELIS J, MICHAELIS H, GLUCK E, KOLLER S: Prospective study of suspected associations between certain drugs administered during early pregnancy and congenital malformations. Teratology (1983) 27:57-64.
38. SETO A, EINARSON T, KOREN G: Pregnancy outcome following first trimester exposure to antihistamine medications: a meta-analysis. Am. J. Perinatol. (1997) 14:119-124.
39. MOSER J, CALDWELL J, RHULE F: No more than necessary: safety and efficacy of low-dose promethazine. Ann. Pharmacother. (2006) 40:45-48.
40. KOUSSEN M: Treatment of nausea and vomiting in pregnancy. Am. Fam. Phys. (1993) 48:1279-1284.
41. KING C, WEAVER S, NARROD S: Antihistamines and teratogenicity in the rat. J. Pharmacol. Exp. Ther. (1965) 147:391-398.
42. POTTS C, ULLERY J: Maternal and fetal effects of obstetric analgesia. Am. J. Obstet. Gynecol. (1961) 81:1252-1259.
43. CZEIZEL A, SZEGAL B, JOFFE J: The effect of diazepam and promethazine treatment during pregnancy on the somatic development of human offspring. Neurotoxicol. Teratol. (1999) 21:157-167.
44. WALKER B, PATTERSON A: Induction of cleft palate in mice by tranquilizers and barbiturates. Teratology (1974) 10:159-164.
45. HANNAH R, ROTH S, SPIRA A: The effects of chlorpromazine and phenobarbital on vasculogenesis in the cerebellar cortex. Acta Neuropathol. (Berlin) (1982) 57:306-308.
46. FARKAS V, FARKAS G: Teratogenic action of hyperemesis in pregnancy and of medication used to treat it. Zentralbl Gynakol (1971) 10:325-330.
47. Micromedex® Healthcare Series. ReproTox®.
48. AUERBACH J, HANS S, MARCUS J, MAEIR S: Maternal psychotropic medication and neonatal behavior. Neurotaxicol. Teratol. (1992) 14:399-406.
49. O'CONNOR M, JOHNSON G, JAMES D: Intrauterine effect of phenothiazines. Med. J. Aust. (1981) 1:416-417.
50. SZABO K, BRENT R: Species differences in experimental teratogenesis by tranquillizing agents. Lancet (1974) 1:565.
51. ROUX C: Action teratogene de la prochlopemazine. Arch. Fr. Pediatr. (1959) 6:968-971.
52. HO C: Congenital malformations. Cleft palate, congenital heart disease, absent tibiae, and polydactyly. Am. J. Dis. Child (1975) 129:714-716.
53. FREEMAN R. Limb deformities: possible association with drugs. Med. J. Aust. (1972) 1:606-607.
54. RAFLA N: Limb deformities associated with prochlorperazine. Am. J. Obstet. Gynecol. (1987) 156:1557-1559.
55. NELSON M, FORFAR J: Associations between drugs administered during pregnancy and congenital abnormalities of the fetus. BMJ (1971) 1:523-527.
56. SLONE D: Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am. J. Obstet. Gynecol. (1977) 128:486-488.
57. KULLANDER S, KALLEN B: A prospective study of drugs and pregnancy. II. Anti-emetic drugs. Acta Obstet. Gynecol. Scand. (1976) 55:105-111.
58. MILKOVICH L, VAN DEN BERG B: An evaluation of the teratogenicity of certain antinauseant drugs. Am. J. Obstet. Gynecol. (1976) 125:244-248.
59. RIEDER R, ROSENTHAL D, WENDER P, BLUMENTHAL H: The offipring of schizophrenics. Fetal and neonatal deaths. Arch. Gen. Psychiatry (1975) 32:200-211.
60. WATANABE N: Teratogenicity of metoclopramide. Yakugaku Kenkyu (1968) 39:92-106.
61. Product information. Reglan® (1997).
62. SORENSON H, NIELSON G, CHRISTENSON K, TAGE-JENSEN U, EKBORN A, BARON J; THE EUROMAP STUDY GROUP: Birth outcome following maternal use of metoclopramide. Br. J. Clin. Pharm. (2000) 343:264-268.
63. BERKOVICH M, ELBRIT D, ADDIS A, SCHULER-FACCINI L, ORNOY A: Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N. Engl. J. Med. (2000) 343:445-446.
64. Product information. Zofran® (1997).
65. TUCKER M, JAAKSON M, SCALES M: Ondansetron: pre-dinical safety evaluation. Eur. J. Clin. Oncol. (1989) 25:S79-S93.
66. GUIKONTES E, SPANTIDEAS A, DIANKAKIS J: Ondansetron and Hyperemesis gravidarum. Lancet (1992) 340:1223-1238.
67. WORLD M: Ondansetron and Hyperemesis gravidarum. Lancet (1993) 341:185-189.
68. TINCELLO D, JOHNSON M: Treatment of Hyperemesis gravidarum with the 5-HT3 antagonist ondansetron (Zofran). Fostgrad. Med. J. (1996) 72:688-689.
69. SULLIVAN C, JOHNSON C, ROACH H, MARTIN R, STEWART D, MORRISON J: A pilot study of intravenous ondansetron for Hyperemesis gravidarum. Am. J. Obstet. Gynecol. (1996) 174:1565-1568.
70. ASKER C, NORSTEDT W, KALLEN B: Use of antiemeric drugs during pregnancy in Sweden. Eur. J. Clin. Pharmacol. (2005) 61:899-906.
71. EINARSON A, MALTEPE C, NAVIOZ Y, KENNEDY D, TAN M, KOREN G: The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. Br. J. Obstet. Gynaecol. (2004) 111:940-943.
72. MAZZOTTA P, MAGEE L: A risk-benefit assessment of pharmacological and nonpharmacological treatments for nausea and vomiting of pregnancy. Drugs (2000) 59:781-800.
73. MAGEE L, MAZZOTTA P, KOREN G: Evidence-based view of safety and effectiveness of pharmacological therapy for nausea and vomiting of pregnancy (NVP). Am. J. Obstet. Gynecol. (2002) 186:S256-S261.
74. EINARSON A, KOREN G, BERGMAN U: The treatment of nausea and vomiting in pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. (1998) 76: 103-106.